首页> 外文会议>Postgraduate Course in Critical Care Medicine >Evidence of biological efficacy for prolonged corticosteroid treatment in unresolving acute respiratory distress syndrome
【24h】

Evidence of biological efficacy for prolonged corticosteroid treatment in unresolving acute respiratory distress syndrome

机译:在未解决的急性呼吸窘迫综合征中延长皮质类固醇治疗的生物疗效证据

获取原文

摘要

Acute respiratory distress syndrome (ARDS) is a disease of multi-factorial etiology characterized by rapid development of severe diffuse and non-homogenous inflammation of the pulmonary lobules, causing life-threatening hypo-xemic respiratory failure. We have tested a therapeutic intervention on a previously defined pathophysiological model of ARDS [1]. The model was defined by investigating during the longitudinal course of ARDS, the relationship among the three fundamental elements of a disease process pathogenesis, structural alterations, and functional consequences [2]. In these studies, we provided biological and morphological evidence indicating that ARDS patients failing to improve after 1 week of mechanical ventilation (unresolving ARDS) have intense and protracted pulmonary and systemic inflammatory and neo-fi-brogenetic activity.
机译:急性呼吸窘迫综合征(ARDS)是一种多因素病因的疾病,其特征在于肺叶片严重弥漫性和非均匀炎症的快速发展,导致危及生命的缺血性呼吸衰竭。我们已经测试了在先前定义的ARDS的病理生理模型上进行治疗干预[1]。该模型由在纵向过程中调查纵向过程中,疾病过程发病机制,结构改变和功能后果的三种基本要素之间的关系[2]。在这些研究中,我们提供了生物学和形态学证据,表明在机械通气1周后未能改善的ARDS患者(未解决的ARDS)具有激烈的肺和全身炎症和新脲活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号